AGGF1P6

Across TCGA pan-cancer cohorts, AGGF1P6 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated AGGF1P6 data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher AGGF1P6 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated AGGF1P6 expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

BRCA, CESC, and THYM are the cancer types where AGGF1P6 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Tertile	All	0.570	1.000	.033	36	view →
CESC	OS	Tertile	IV	0.121	0.591	.029	36	view →
THYM	DFS	Tertile	All	0.174	0.759	.028	27	view →
SARC	DFS	Tertile	All	0.143	0.617	<.001	21	view →
STAD	OS	Tertile	IV	0.074	0.540	.024	18	view →
OV	OS	Tertile	All	0.583	0.697	.032	18	view →
UCEC	DFS	Tertile	All	0.692	0.847	.005	18	view →
KIRC	DFS	Tertile	All	0.262	0.634	.011	12	view →
SKCM	DFS	Tertile	All	0.707	0.575	.002	11	view →
PAAD	OS	Tertile	II,III,IV	0.342	0.572	.018	9	view →
LUSC	OS	Tertile	All	0.642	0.826	.047	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

AGGF1P6–BRCA (DFS)

Open the BRCA breakdown →